gRNA Market (By Product and Service Type: Products, gRNA Final Products, gRNA Synthesis Products, gRNA Synthesis Kits, Plasmids, Others, Custom gRNA Synthesis Services; By gRNA Type: Research-use, GMP-grade; By Application: Genome Engineering, Disease Model Studies, Functional Genomics, Epigenetics, Others; By End-use: Pharmaceutical & Biotechnology Companies, Academic Research Institutes, CMOs and CROs) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on GRNA Market
5.1. COVID-19 Landscape: GRNA Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global GRNA Market, By Product & Service Type
8.1. GRNA Market Revenue and Volume Forecast, by Product & Service Type, 2024-2033
8.1.1. Products
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Custom gRNA Synthesis Services
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global GRNA Market, By GRNA Type
9.1. GRNA Market Revenue and Volume Forecast, by GRNA Type, 2024-2033
9.1.1. Research-use
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. GMP-grade
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global GRNA Market, By Application
10.1. GRNA Market Revenue and Volume Forecast, by Application, 2024-2033
10.1.1. Genome Engineering
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Genome Engineering
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Genome Engineering
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Epigenetics
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
10.1.5. Others
10.1.5.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global GRNA Market, By End-use
11.1. GRNA Market Revenue and Volume Forecast, by End-use, 2024-2033
11.1.1. Pharmaceutical & Biotechnology Companies
11.1.1.1. Market Revenue and Volume Forecast (2021-2033)
11.1.2. Academic Research Institutes
11.1.2.1. Market Revenue and Volume Forecast (2021-2033)
11.1.3. CMOs & CROs
11.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 12. Global GRNA Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)
12.1.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)
12.1.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.1.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)
12.1.5.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)
12.1.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.1.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)
12.1.6.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)
12.1.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.1.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)
12.2.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)
12.2.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)
12.2.5.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)
12.2.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)
12.2.6.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)
12.2.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)
12.2.7.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)
12.2.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.7.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)
12.2.8.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)
12.2.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)
12.3.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)
12.3.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)
12.3.5.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)
12.3.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)
12.3.6.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)
12.3.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)
12.3.7.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)
12.3.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.7.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)
12.3.8.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)
12.3.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)
12.4.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)
12.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)
12.4.5.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)
12.4.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)
12.4.6.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)
12.4.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)
12.4.7.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)
12.4.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.7.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)
12.4.8.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)
12.4.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)
12.5.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)
12.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)
12.5.5.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)
12.5.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.5.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Product & Service Type (2021-2033)
12.5.6.2. Market Revenue and Volume Forecast, by GRNA Type (2021-2033)
12.5.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.5.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
Chapter 13. Company Profiles
13.1. Synthego
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Abbott
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Horizon Discovery Ltd
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Synbio Technologies
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Takara Bio Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. GENEWIZ (Azenta Life Sciences)
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Merke KGaA
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Jena Bioscience GmbH
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. System Biosciences, LLC
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Agilent Technologies Inc.
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample